{
    "id": 30731,
    "fullName": "TERT positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "TERT positive indicates the presence of the TERT gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 7015,
        "geneSymbol": "TERT",
        "terms": [
            "TERT",
            "CMM9",
            "DKCA2",
            "DKCB4",
            "EST2",
            "hEST2",
            "hTRT",
            "PFBMFT1",
            "TCS1",
            "TP2",
            "TRT"
        ]
    },
    "variant": "positive",
    "createDate": "08/16/2019",
    "updateDate": "08/16/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 18144,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II trial, 58% (11/19) of patients with acute myeloid leukemia treated with AST-VAC1 demonstrated an hTERT-specific-T-cell response and 58% (11/19) had disease free recurrence at 52 month follow-up (PMID: 28411378).",
            "molecularProfile": {
                "id": 32976,
                "profileName": "TERT positive"
            },
            "therapy": {
                "id": 8672,
                "therapyName": "AST-VAC1",
                "synonyms": null
            },
            "indication": {
                "id": 9119,
                "name": "acute myeloid leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 16009,
                    "pubMedId": 28411378,
                    "title": "Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28411378"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 20248,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, INVAC-1 treatment delayed tumor growth and increased survival of a TERT-positive aggressive sarcoma mouse model (PMID: 27141336).",
            "molecularProfile": {
                "id": 32976,
                "profileName": "TERT positive"
            },
            "therapy": {
                "id": 9302,
                "therapyName": "INVAC-1",
                "synonyms": null
            },
            "indication": {
                "id": 1115,
                "name": "sarcoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17784,
                    "pubMedId": 27141336,
                    "title": "Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27141336"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32976,
            "profileName": "TERT positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}